Papayannidis, C., Sartor, C., Dominietto, A., Zappone, E., Arpinati, M., Marconi, G., Cristiano, G., Nanni, J., Parisi, S., Barbato, F., Paolini, S., Soverini, S., Terragna, C., Robustelli, V., Testoni, N., Chirumbolo, G., Curti, A., Cavo, M., & Bonifazi, F. (2021). inotuzumab ozogamicin and donor lymphocyte infusion is a safe and promising combination in relapsed acute lymphoblastic leukemia after allogeneic stem cell transplant. Hematological oncology, 39(4), 580–583. http://access.bl.uk/ark:/81055/vdc_100144251470.0x000034